The Sriwijaya University Library

  • Home
  • Information
  • News
  • Help
  • Librarian
  • Login
  • Member Area
  • Select Language :
    Arabic Bengali Brazilian Portuguese English Espanol German Indonesian Japanese Malay Persian Russian Thai Turkish Urdu

Search by :

ALL Author Subject ISBN/ISSN Advanced Search

Last search:

{{tmpObj[k].text}}
Image of PENGGUNAAN KELASI BESI DEFERASIROX DAN PENURUNAN KADAR FERRITIN SERUM PASIEN THALASSEMIA MAYOR ANAK

Skripsi

PENGGUNAAN KELASI BESI DEFERASIROX DAN PENURUNAN KADAR FERRITIN SERUM PASIEN THALASSEMIA MAYOR ANAK

Nurza, Mgs Ammar Agustian - Personal Name;

Penilaian

0,0

dari 5
Penilaian anda saat ini :  

Background: Pediatric thalassemia major require lifelong blood transfusions to compensate inadequate erythrocyte. However, regular blood transfusions cause iron overload. In addition, pathologically in thalassemia, there is also iron accumulation due to faster hemolysis and ineffective erythropoiesis process. Iron overload is toxic for organ so that it must be removed using iron chelation, one of which is deferasirox. This study aims to determine the best dose of deferasirox to reduces serum ferritin in pediatric thalassemia major at Dr. Mohammad Hoesin Hospital Palembang. Methods: This descriptive observational study was conducted at Dr. Mohammad Hoesin Hospital Palembang from October to December 2024. There were 69 samples that met the inclusion criteria from total 208 samples. Data were analyzed using SPSS version 27 in the form of frequency distribution and grouping through ROC Analysis. Results: The characteristics of the samples were mostly in the age group of 10-18 years (49.3%), the majority were diagnosed with thalassemia ≤5 years (71%), and the majority had blood transfusions ≥12 times/year (59.4%). The greatest decrease in serum ferritin in the 31-40 mg/kg/day dose group (6.710.2µg/L), however, the number of samples who experienced a decrease in serum ferritin levels was greatest using the 21-30 mg/kg/day dose (57,8%) of the total samples that experienced a decrease ferritin serum Conclusion: The use of deferasirox doses in pediatric thalassemia major at Dr. Mohammad Hoesin Palembang Hospital which experienced the most decline was at a dose of 21-30 mg/kg/day. Keywords: Thalassemia, deferasirox, ferritin


Availability
Inventory Code Barcode Call Number Location Status
2407006858T161388T1613882024Central Library (REFERENCE)Available but not for loan - Not for Loan
Detail Information
Series Title
-
Call Number
T1613882024
Publisher
Indralaya : Prodi Pendidikan Kedokteran, Fakultas Kedokteran Universitas Sriwijaya., 2024
Collation
ix, 86 hlm.; ilus.; 29 cm
Language
Indonesia
ISBN/ISSN
-
Classification
616.152 07
Content Type
Text
Media Type
unmediated
Carrier Type
-
Edition
-
Subject(s)
Prodi Pendidikan Kedokteran
Thalassemia Mayor - Terapi Kelasi Besi
Specific Detail Info
-
Statement of Responsibility
TUTI
Other version/related

No other version available

File Attachment
  • PENGGUNAAN KELASI BESI DEFERASIROX DAN PENURUNAN KADAR FERRITIN SERUM PASIEN THALASSEMIA MAYOR ANAK
Comments

You must be logged in to post a comment

The Sriwijaya University Library
  • Information
  • Services
  • Librarian
  • Member Area

About Us

As a complete Library Management System, SLiMS (Senayan Library Management System) has many features that will help libraries and librarians to do their job easily and quickly. Follow this link to show some features provided by SLiMS.

Search

start it by typing one or more keywords for title, author or subject

Keep SLiMS Alive Want to Contribute?

© 2025 — Senayan Developer Community

Powered by SLiMS
Select the topic you are interested in
  • Computer Science, Information & General Works
  • Philosophy & Psychology
  • Religion
  • Social Sciences
  • Language
  • Pure Science
  • Applied Sciences
  • Art & Recreation
  • Literature
  • History & Geography
Icons made by Freepik from www.flaticon.com
Advanced Search